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Background/aim: It was aimed to describe the technical aspects and outcomes of percutaneous ultrasound-guided recanalization of
thrombosed hemodialysis fistulas by thrombolytic injection.
Materials and methods: A retrospective review was performed on patients with thrombosed native hemodialysis fistula who were
treated using the percutaneous ultrasound-guided thrombolytic agent injection technique at the interventional radiology department.
A total of 17 patients [7 women (41.2%) and 10 men (58.8%)] were included in this study. All of the data, including demographic
information and clinical findings, were obtained from the patients’ medical records and follow-up form of the procedure.
Results: The mean fistula age was 5.6 years (range: 1–15 years). The mean diameter of the thrombosed segment was 5.53 cm (2–10 cm).
Localization of the thrombi was in the aneurysmal segment at the level of needle insertion in 64.7% (n: 11) of patients, while it was on
the venous side of the anastomosis in 35.3% (n: 6). The mean dose of tissue plasminogen activator (tPA) used in all of the sessions was
8.88 mg (5–17 mg). Overall technical success after all of the administrations was 100% and clinical success was 94.1%.
Conclusion: Percutaneous ultrasound-guided thrombolytic injection in native hemodialysis fistulas is a rapid, practical, repeatable
treatment method that is received on an outpatient basis with low risk of bleeding, and prevents unnecessary endovascular interventions
or surgical operations.
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1. Introduction
Chronic kidney disease (CKD) is an important health
problem affecting people worldwide by virtue of high
morbidity and mortality. Due to developing dialysis
technology and therapies, the life-span and quality of
life in patients undergoing hemodialysis with CKD is
increased. Native arteriovenous fistula (AVF), synthetic
loop grafts, and large-bore tunneled or temporary central
venous catheters are the alternative hemodialysis methods
for patients who cannot undergo renal transplant [1,2].
Among these options, native AVF is the first and most
durable choice for vascular access because of the lower
thrombotic and infectious complications [1,3].
Thrombosis is one of the most severe complications
and is influential to morbidity and hospitalization in
hemodialysis patients [4]. Diagnosis and endovascular
treatment in the dysfunction of hemodialysis fistulae and
grafts have been successfully performed by interventional
radiologists over the last decades. Mechanical
thrombectomy, pharmacomechanical thrombolysis, and

pharmacologic thrombolysis via percutaneous infusion are
currently being used for the management of hemodialysis
vascular access [5].
The main objectives of endovascular/interventional
procedures are to be minimally invasive, fast, and effective;
thus, shortening the length of hospital stay and aiding in
a quick return to daily life. Based on these objectives, a
new technique for the treatment of thrombosed native
hemodialysis fistulas was designed using an ultrasound,
needle, and tissue plasminogen activator (tPA).
The purpose of this study was to evaluate the technical
aspects and outcomes of percutaneous ultrasound-guided
recanalization of thrombosed hemodialysis fistulas by
thrombolytic agent injection.
2. Materials and methods
2.1. Patients
The medical records of patients who underwent
percutaneous treatment for thrombosed hemodialysis
fistulas were reviewed. A total of 17 patients [7 women
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(41.2%) and 10 men (58.8%)] were included in this
study, from May 2012 to September 2017. Patients from
hemodialysis centers and cardiovascular surgery with
dysfunction of native hemodialysis fistulas were referred
for the diagnosis and management of the recanalization.
B-mode and Doppler ultrasonography (US) was used as
the imaging method to detect the cause of dysfunction.
None of the patients had a history of percutaneous
transluminal angioplasty (PTA) or stent implantation due
to stenosis or occlusion of a prior the hemodialysis fistula
thrombosis.
All of the data, including demographic information and
clinical findings, were obtained from the patients’ medical
records and follow-up form for the procedure (Table 1).
The exclusion criteria for percutaneous treatment were
an infected AVF, patients with hemostasis and bleeding
disorders, the presence of chronic wall-adherent thrombi
(>4 weeks old) and long segment thrombosis (>10 cm).
Patients with nonthrombosed dysfunctional hemodialysis
fistulas (low thrill) were also excluded from the study, as
they were in need of endovascular fistulography.
Informed consent was obtained before initiating
treatment and the ethics committee approved the study
design.
2.2. Technique
In this study, the procedure was applied to outpatients
without requiring hospitalization. Patients were primarily

evaluated for the convenience of the procedure. For this
purpose, patients referred from dialysis centers that were
suspected of having thrombosis were evaluated with US.
Thrombus on the venous side of a hemodialysis fistula
that restricted the flow or completely led to occlusion, with
a sonographic view suggesting acute and subacute stage,
in patients with a clinical history of less than 4 weeks and
coagulation parameters within normal limits (INR of <1.5,
PLT of >50,000/mm3) were accepted for treatment. The
length, location, and nature of the thrombosis and fistula
characteristics were recorded using Doppler ultrasound.
After providing appropriate sterile conditions, using a
27-gauge (G) needle with a 5-cc conventional syringe,
5–10 mg of tPA was percutaneously injected into different
localizations of the thrombus by entering different
points of the skin. Particular attention was paid to the
administration of the tPA into the thrombus, and the
procedure was performed in a controlled manner under
US guidance (Loqic S6, GE Healthcare, USA). Local
anesthesia was provided at the puncture sites with 1%
lidocaine. No prophylactic antibiotic was administered.
In most patients, the thrombus started to dissolve during
the injections (Figure 1). After each procedure, the arteries
and veins associated with the fistula were evaluated by
Doppler US. If the central veins could not be evaluated
with Doppler US, fistulography was performed in order
to see the underlying pathology. After tPA administration,

Table 1. Patient demographic, AVF, and procedure-related data.
Patients
Female

7

41.2%

Male

10

58.8%

Mean age (range)		

56.06 years (range: 32–77 years)

AVF types
End-to-side radiocephalic

12

70.6%

End-to-side brachiocephalic

3

17.6%

End-to-end radiocephalic

1

5.9%

End-to-side brachiobasilic

1

5.9%

Mean fistula age

5.6 years

(range: 1–15 years)

Acute (≤2 week old)

9

52.9%

Subacute (3–4 weeks old)

8

47.1%

Mean length of the thrombosed segment

5.53 cm

(range: 2–10 cm)

Aneurysmal segment

11

64.7%

Venous side of the anastomosis

6

35.3%

Mean dose of tPA (total of 20 sessions)

8.8 mg

(range: 5–17 mg)

Mean dose of tPA (3 additional sessions)

5.6 mg

(range: 5–7 mg)

Thrombus age

The localization of thrombi
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Figure 1. A 58-year-old male patient referred due to radiocephalic end-to-side native AV fistula dysfunction. The
thrombus (A) detected at the level of the aneurysmal segment. A 27-G needle (B) was advanced percutaneously into
the thrombus, and after tPA injection (C). Partial recanalization in the lumen was observed during the procedure (D).

the patients were advised to massage this area for
approximately 10–15 min every hour during the day to
facilitate homogenous spread of the tPA to the thrombosed
segment. The patients were kept under observation for
approximately 2 h for close follow-up of any complications
after the procedure. The patients were sent home 2 h after
that and called the next day to check their lumen patency
(Figure 2). An additional dose of percutaneous tPA (mean:
5.6 mg, range: 5–7 mg) was administered to patients who
did not have sufficient patency at their check-up. Patients
who received an additional dose were then again called for
a check-up after 1 day. In the US check-ups performed after

the first or second session, postprocedure flow-volume
rates (700–1300 mL/min) were measured by Doppler US
to evaluate the adequate patency for sufficient dialysis [6].
Otherwise, patients needed fistulography to determine
additional pathologies. The use of an anticoagulant was
recommended in those patients to reduce the risk of
recurrent thrombosis. Patient follow-ups were made by
contacting their dialysis centers and getting information
about the status of their dialysis sessions after the procedure.
In the case of the recurrence of missed dialysis sessions,
the patients were redirected to us and checked by dialysis
fistulography to identify additional pathologies that led to
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Figure 2. Thrombus at the site of an aneurysmal segment in a 72-year-old male patient with brachiocephalic end-to-side fistula is seen
(A). Percutaneous ultrasound-guided tPA injection was performed (B). Doppler ultrasound revealed the complete patency in the lumen
at the first day check-up (C).

the thrombosis. Patients with stenosis or occlusions at the
anastomosis, efferent vein, or central vein were treated via
endovascular methods.
2.3. Definitions
An aneurysmal segment was defined as dilation twice that
of the normal draining vein or dilation that was >3 cm in
diameter. Technical success was defined as <30% residual
diameter in stenosis after treatment. Clinical success after
the thrombolytic injection was defined as the resumption of
normal dialysis for at least 2 sessions. Primary patency was
defined as the interval following the thrombolytic injection
until insufficient lumen patency. Secondary patency was
defined as the endovascular treatment of the central vein
or outflow draining vein by angioplasty, with or without
stent implantation. Complications were categorized as
major or minor. Major complications included those
requiring therapy or hospitalization, causing permanent
adverse sequelae, or death. Minor complications were
those requiring no or nominal therapy [7].
2.4. Statistical analysis
Numeric data were presented as the average, standard
deviation, median, maximum, and minimum, while
categorical data were pre
sented as the number and
percentage. Statistical data editing and analysis were per
formed using SPSS (IBM Corp., Armonk, NY, USA) v.20.0
software.
3. Results
A total of 17 patients with thrombosed native hemodialysis
fistulas (7 women and 10 men; mean age: 56.06 years,
range: 32–77 years, SD 12.96 years) were included in the
study. The patients were mainly referred from dialysis
centers due to failure of a dialysis session. The types of
AVFs were end-to-side radiocephalic (n: 12, rate: 70.6%),
end-to-side brachiocephalic (n: 3, rate: 17.6%), end-
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to-end radiocephalic (n: 1, rate: 5.9%), and end-to-side
brachiobasilic (n: 1, rate: 5.9%). AVFs were located on the
right upper limb in 7 patients and on the left in 10 patients.
The mean fistula age was 5.6 years (range: 1–15 years).
Intravenous clots treated by percutaneous ultrasoundguided thrombolytic injection (≤4 weeks old) were divided
into 2 subgroups, as acute (≤2 weeks old) and subacute
(3–4 weeks old), 52.9% (n: 9) and 47.1% (n: 8), respectively.
The mean length of the thrombosed segment was 5.53 cm
(range: 2–10 cm, SD: 2.26 cm). Localization of thrombi was
in the aneurysmal segment at the level of needle insertion
in 64.7% (n: 11) of patients, while it was on the venous
side of the anastomosis in 35.3% (n: 6). The degree of
thrombosis was total in 9 patients (52.9%) and partial in
8 patients (47.1%). Considering of all of the patients, 20
sessions of percutaneous ultrasound-guided thrombolytic
injection procedure were performed and a total of 151 mg
of tPA was used. The mean dose of tPA used in all of the
sessions was 8.88 mg (range: 5–17 mg, SD: 3.95 mg) (Table
1).
Central venous catheterization is known to be a risk
factor for central vein stenosis or occlusion. In 3 patients
(17.7%), there was no medical history of catheter insertion.
In 14 patients (82.3%), there was a history of permanent or
temporary dialysis catheter insertion in the side of fistula
or counter.
Overall, the technical success after all of the
administrations was 100% and clinical success was 94.1%
(16 of 17 patients). In 3 patients (17.7%), insufficient
lumen patency was detected, thus a second session of
thrombolytic injection was needed on the first day checkup. In 3 patients, after 2 sessions of thrombolytic injection,
and in 1 patient, after the diagnosis of underlying stenosis
in the outflow draining vein, endovascular treatment was
needed, after a mean number of 3.7 dialysis sessions. As the
endovascular treatment, PTA for the efferent vein stenosis
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in 2 patients, PTA for the central vein stenosis in 1 patient,
and PTA with stenting for central vein stenosis in 1 patient
was performed due to repetition of the AVF dysfunction.
The primary patency rate was 82.3% and secondary patency
rate was 76.5% (Table 2).
Minor hemorrhage was resolved in 1 patient by manual
compression. During and after the procedures, no major
complications were encountered.
4. Discussion
In hemodialysis patients, early recognition and treatment
of complications like thrombosis is important for long-term
and effective use of the fistula. Thrombosis is a frequent
complication in native hemodialysis fistulas and the
underlying pathology is mostly an aneurysmatic segment
causing flow turbulences and stenosis in the outflow
or central vein [8]. In addition to outflow pathologies,
hypotension, low cardiac output, reduction in the arterial
flow due to stenosis, and clotting problems can lead to
thrombosis [9]. Native AVF thromboses are often recognized
by insufficient flow during routine dialysis sessions, as in
the current study. Dialysis staff may refer a patient with
complaints of cannulation difficulty or aspirating clot. This
patient needs immediate hemodialysis, and therefore must
undergo the placement of a temporary dialysis catheter
until the declotting procedure. Conventional treatments for
AV fistula deficiencies include surgical thrombectomy, new
shunting in the proximal side of the old AVF, patch plasty
or bridge graft procedures with autogenous or synthetic
grafts, and arterial or venous bypass procedures. Although
the long-term results of these procedures are acceptable,
they are not preferred for reasons such as being more
invasive than endovascular treatments and not allowing
early cannulation; thus, temporary dialysis catheterization
is needed [10].
Endovascular procedures in interventional radiology
have increased in number thanks to the rapid development
of equipment and expanding field of imaging. The main
techniques used for the declotting of AVFs in interventional
radiology are catheter-directed thrombolysis, catheterdirected mechanical thrombectomy. and angioplasty, with
or without stenting [11].
Considering the workload in interventional radiology
departments and the necessity of continuity of dialysis
sessions for their hemodialysis patients, the quest for
effective, practical, and rapid treatment methods, for
both the practitioner and patient, gave rise to the idea of
percutaneous ultrasound-guided thrombolytic injection for
recanalization of thrombosed native hemodialysis fistulas.
Using this method, thromboses that led to missed dialysis
sessions were treated using only an ultrasound, needle, and
tPA. This technique was chosen specifically for thromboses
not longer than 10 cm, as it was believed that a thrombolytic
infusion catheter would be more effective in long segments

Table 2. Success and patency rates of the treatment.
Overall technical success

100%

Clinical success

94.1%

Primary patency rate

82.3%

Secondary patency rate

76.5%

of thrombosis.
Aside from the difficulty of placing the thrombolytic
infusion catheter in the thrombus and fixing the catheter
to this point in short segment fistula thrombi, due to the
use of a long infusion catheter, the risk of hemorrhagic
complications may be increased because some of the
given tPA will pass into the systemic circulation outside
of the thrombosed segment. Herein, the tPA dose injected
percutaneously was 5–10 mg mean per session and it was
administered only locally into the thrombus; thus, the risk
of bleeding complications was significantly lower due to
the lack of transition to the systemic circulation and was
thought to have completed its half-life by acting within the
thrombus.
Thanks to this technique, the thrombus at the site of
the dialysis cannulation was treated successfully in 76.5%
(n: 13/17) of the patients, thus prevented from unnecessary
endovascular intervention as well as surgery. Moreover,
an average number of 3.7 dialysis session continuity
was maintained in 4 patients that subsequently needed
endovascular intervention due to outflow vein stenosis.
The advantage of percutaneous treatment in those 4
patients was to reduce the burden of thrombus and allow
us to visualize the underlying stenosis by fistulography.
Moreover, the use of fluoroscopy, owing to the ultrasoundguided technique, in proper cases was reduced. Flowvolume rates of the AVFs were measured using Doppler
US after the procedure to show the adequate patency for
dialysis. In the event of low flow-volume rates despite the
lysis of the thrombus, fistulography was needed to show the
outflow pathologies.
The retrospective design of the study was the main
limitation, in addition to the study group being limited in
number.
As a conclusion, percutaneous ultrasound-guided
thrombolytic injection in native hemodialysis fistulas is
a rapid (approximately 15–30 min), practical, repeatable
treatment method, received on an outpatient basis with low
risk of bleeding that prevents unnecessary endovascular
interventions or surgical operations. Since this technique
has not been described previously in the literature, we
believe that a comparison of endovascular methods and
the percutaneous technique described herein should be
performed with larger patient groups.

1183

DURMAZ and BİRGİ / Turk J Med Sci
References
1.

Zaleski G. Declotting, maintenance, and avoiding procedural
complications of native arteriovenous fistulae. Seminars in
Interventional Radiology 2004; 21 (2): 83-93.

6.

Zamboli P, Fiorini F, D’Amelio A, Fatuzzo P, Granata A.
Color Doppler ultrasound and arteriovenous fistulas for
hemodialysis. Journal of Ultrasound. 2014; 17 (4): 253-263.

2.

Mammen S, Keshava SN, Moses V, Babu S, Varughese S.
Pictorial essay: Interventional radiology in the management
of hemodialysis vascular access - a single-center experience.
Indian Journal of Radiology and Imaging 2012; 22 (1): 14-18.

7.

Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of
Interventional Radiology Clinical Practice Guidelines. Journal
of Vascular and Interventional Radiology 2003; 14: 199-202.

3.

Santoro D, Benedetto F, Mondello P, Pipitò N, Barillà D et
al. Vascular access for hemodialysis: current perspectives.
International Journal of Nephrology and Renovascular
Disease 2014; 8 (7): 281-294.

8.

Schwab S, Raymond J, Saeed M, Newman G, Dennis P et al.
Prevention of hemodialysis fistula thrombosis: Early detection
of venous stenoses. Kidney International 1989; 36: 707-711.

9.

Vorwerk D, Schurmann K, Muller-Leisse C, Adam G, Bucker
A et al. Hydrodynamic thrombectomy of hemodialysis grafts
and fistulae: Results of 51 procedures. Nephrology Dialysis
Transplantation 1996; 11: 1058-1064.

10.

Hastaoglu IA, Tokoz H, Bilgen F. Endovascular treatments in
AV fistula failures; technique, literature review and our early
results. Turkish Journal of Vascular Surgery 2016; 25 (3): 110116.

11.

Bent CL, Sahni VA, Matson MB. The radiological management
of the thrombosed arteriovenous dialysis fistula. Clinical
Radiology 2011; 66 (1): 11-12.

4.

5.

Ahn SY, So YH, Choi YH, Jung IM, Chung JK. Endovascular
recanalization of a thrombosed native arteriovenous fistula
complicated with an aneurysm: technical aspects and
outcomes. Korean Journal of Radiology 2015; 16 (2): 349-356.
Haage P, Vorwerk D, Wildberger JE, Piroth W, Schürmann
K et al. Percutaneous treatment of thrombosed primary
arteriovenous hemodialysis access fistulae. Kidney
International 2000; 57 (3): 1169-1175.

1184

